Purchases and Sales Made in Q2 2022 in Bright Minds Biosciences Inc. (DRUG)
This table provides information about the institutional ownership of Bright Minds Biosciences Inc. (DRUG) during Q2 2022. The information is specifically focused on institutions that hold shares of BRIGHT MINDS BIOSCIENCES INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 08, 2022
Q2 2022
|
Advisor Shares Investments LLC
Bethesda, MD |
BUY
|
- |
82.9K+ 40.08% |
$66.3K - $130K
|
290K
$11.4M
|
|
|
Aug 10, 2022
Q2 2022
|
Ubs Group Ag
|
BUY
|
- |
3.83K+ 110.87% |
$3.06K - $6.01K
|
7.28K
$287K
|
|
|
Aug 15, 2022
Q2 2022
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
1.34K+ 560.67% |
$1.07K - $2.1K
|
1.58K
$62.3K
|
|
|
Aug 09, 2022
Q2 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 16, 2022
Q2 2022
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-1- -0.0% |
$0.8 - $1.57
|
24.7K
$975K
|
|
|
Aug 09, 2022
Q2 2022
|
Virtu Financial LLC
New York, NY |
SELL
|
- |
-14.6KClosed |
$11.6K - $22.9K
|
0
$0
|